Jennifer Walker-Journey

4574 posts

Jennifer Walker-Journey is a professional writer whose 20-year career spans from newspapers and magazines to Ezines and business blogs. Her primary focus is corporate and business writing, though she relishes any opportunity to write features. In her limited free time, Jennifer strives to finish the novel she is writing. She lives in Birmingham with her husband, Rick, and their insatiably curious son, Truman.

Zofran for morning sickness linked to birth defects

Pregnant Girl

Lawsuits in a multidistrict litigation (MDL) alleging birth defects from anti-nausea drug Zofran have increased substantially according to a Reuters analysis of statistics from the U.S. Judicial Panel on Multidistrict litigation. Zofran, known chemically as ondansetron, is manufactured by GlaxoSmithKline. It is approved to treat nausea for patients undergoing chemotherapy and following surgery, and works by blocking serotonin in the areas of the brain that trigger nausea and vomiting. From 2002 to 2004, GlaxoSmithKline began marketing Zofran for the treatment of morning sickness in pregnant women, an indication the drug was not approved to treat. Doctors have the discretion of ... Read More

Viagra may prevent diabetes, but increase melanoma risk


The erectile dysfunction drug Viagra may help prevent type 2 diabetes in people at risk for the disease, but it may also put them at risk for a deadly form of skin cancer. A small clinical trial published in the Journal of Clinical Endocrinology & Metabolism found that Viagra, known chemically as sildenafil, improved insulin sensitivity on overweight people with pre-diabetes. Viagra was also found not to increase the risk of heart or kidney disease. The trial involved just 42 patients, both men and women who were overweight and had been diagnosed with pre-diabetes, a condition in which blood sugar ... Read More

Patients with Type 2 diabetes sought for clinical trial comparing medications


More than 50 medical centers associated with universities across the country are recruiting patients with type 2 diabetes to participate in a five-year study to determine the best prescription drug to treat high blood sugar. The study is being conducted by National Institute of Diabetes and Digestive and Kidney Diseases. A total of 5,000 participants is being sought. Those who wish to join the clinical trial should have been diagnosed with type 2 diabetes within the past 10 years and currently be taking the widely used anti-diabetes drug Metformin. Those who are accepted into the program will receive compensation for their ... Read More

FDA warns intravascular medical device coatings may peel, cause injuries


The Food and Drug Administration (FDA) is warning of problems with the coatings on intravascular medical devices, including intravascular catheters, guidewires, balloon angioplasty catheters, delivery sheaths, and implant delivery systems, that can cause serious injury to patients. The FDA Safety Alert comes after nearly a dozen recalls and 500 reports of defects with the devices. “The FDA wants to make health care providers aware of the possibility that hydrophilic and/or hydrophobic coatings may separate (e.g., peel, flake, shed, delaminate, slough off) from medical devices and potentially cause serious injuries to patients,” the FDA said in the Safety Alert. “Coating separation ... Read More

FDA issues warning letter to medical device maker C.R. Bard

IVC filter

Medical device manufacturer C R. Bard was slapped with a warning letter from the Food and Drug Administration (FDA) over misfiling customer complaints that included one patient death, manufacturing a high-risk medical device without required agency approval, and failing to notify the FDA of serious device malfunctions. The FDA letter addresses Bard’s manufacturing and marketing of the Recovery Cone Removal System, used to retrieve inferior vena cava filters, also known as Retrievable IVC filters. The cage-like filters are implanted in the body’s largest vein, called the vena cava, to capture blood clots before they reach the heart and lungs. The devices ... Read More

Victoza studied in obese patients with pre-diabetes

bathroom scale

People who are obese and pre-diabetic can lose weight and delay the onset of type 2 diabetes by more than three years if they take a newer diabetes medication, according to a study presented at ObesityWeek 2015. However, the medication puts users at risk for dangerous side effects. The study involved the type 2 diabetes drug liraglutide, known by the brand name Victoza, which was approved by the Food and Drug Administration (FDA) in 2010. In December 2014, the agency approved a higher dose of the drug, marketed as Saxenda, for weight loss in obese non-diabetics, and for overweight patients ... Read More

Diabetes drug tested as treatment for non-alcoholic fatty liver disease


Researchers are testing type 2 diabetes drug Victoza as a possible treatment for non-alcoholic fatty liver disease, the most common form of liver disease in the United States, affecting about 20 percent of the population. The condition describes a wide range of conditions that are caused when fat builds up within the liver. Non-alcoholic steathohepatitis, or NASH, is the most serious form of the disease, and can lead to total liver failure requiring liver transplant. NASH is known as a silent killer because it does not present with many symptoms and those affected generally feel well. Risk factors include obesity, ... Read More

Warming blanket linked to infection risk in joint replacement patients

Bair Hugger

More than 50 patients who have undergone orthopedic surgery have filed lawsuits against the makers of a popular warming blanket used to keep patients warm during surgery, claiming the machine can circulate contaminated air and cause debilitating infections deep inside joints. The Bair Hugger, manufactured by 3M Company and its subsidiary Arizant Healthcare, pushes warm air through a flexible hose into a blanket that is draped over a patient during surgery. Researchers have found that the air within the blankets can become contaminated, and as the air blows over surgical sites, it can cause infections including MRSA and sepsis. Patients ... Read More

Death prompts Nevada officials to issue cryotherapy guidelines

cryotherapy, cryosauna, LeBron James

The Nevada Department of Public Health has issued guidelines for cryotherapy just weeks after a spa employee was found dead in a cryotherapy chamber. Full-body cryotherapy is a growing interest, promoted as a treatment to reduce pain, speed recovery and improve spirits. Some providers claim the treatment can prevent osteoporosis, treat asthma, improve libido, and speed weight loss. Cryotherapy chambers are padded cylinders that are open at the top. Users stand inside the machines with their heads sticking out the top while the machine encases them in a minus-300-degree nitrogen-rich gas. Chelsea Ake-Salvacion, 24, accidentally asphyxiated and died last month ... Read More

Johnson and Johnson’s knowledge of power morcellator risks questioned


Rep. Tim Murphy, chairman of the Subcommittee on Oversight and Investigations questioned whether Johnson & Johnson and Brigham & Young Hospital violated federal law by not reporting reports of cancer spread in patients who had undergone hysterectomies and uterine fibroid removals using power morecellator tools. During a hearing by the Subcommittee on Health, Murry asked Jeffrey Shuren, director of the FDA Center for Devices and Radiological Health, “Are you aware of this problem?” meaning whether manufacturers of power morcellators, including Johnson & Johnson, or the hospitals that used them had failed to notify the agency of any adverse events, according to ... Read More